Therapeutic plasma exchange for neuromyelitis optica attacks: Evidence and challenges from a real-world cohort from Brazil

J Neuroimmunol. 2024 Mar 15:388:578295. doi: 10.1016/j.jneuroim.2024.578295. Epub 2024 Jan 24.

Abstract

Therapeutic plasma exchange (TPE) can improve disability recovery after neuromyelitis optica spectrum disease (NMOSD) attacks, but its effectiveness and safety in Latin-American patients with access barriers and diverse ethnicity is underexplored. We carried out a retrospective cohort study with NMOSD patients that underwent TPE. 84 NMOSD attacks in 68 patients were evaluated. Despite a median 25-day delay from symptom onset to TPE, 65,5% of patients showed significant improvement. Adverse events occurred in 39% of patients, usually transitory and with no fatalities.

Keywords: Neuromyelitis optica spectrum disease; Therapeutic plasma exchange.

MeSH terms

  • Aquaporin 4
  • Brazil / epidemiology
  • Ethnicity
  • Humans
  • Neuromyelitis Optica* / diagnosis
  • Plasma Exchange
  • Retrospective Studies

Substances

  • Aquaporin 4